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Summary 
At the primary structure level, the 90-kDa heat shock protein (HSP90) is composed of 3 
regions: the N-terminal (Met1-Arg400), middle (Glu401-Lys615) and C-terminal 
(Asp621-Asp732) regions.  In the present study, we investigated potential sub-region 
structures of these 3 regions and their roles.  Limited proteolysis revealed that the 
N-terminal region could be split into 2 fragments carrying residues Met1-Lys281(or 
Lys283) and Glu282(or Tyr284)-Arg400.  The former is known to carry the 
ATP-binding domain.  The fragments carrying the N-terminal two-thirds 
(Glu401-Lys546) and C-terminal one-third of the middle region were sufficient for the 
interactions with the N- and C-terminal regions, respectively.  Yeast HSC82 that 
carried point mutations in the middle region causing deficient binding to the N-terminal 
region could not support the growth of HSP82-depleted cells at an elevated temperature.  
Taken together, our both data show that the N-terminal and middle regions of the 
HSP90-family protein are structurally divided into 2 respective sub-regions.  Moreover, 
the interaction between the N-terminal and middle regions is essential for the in vivo 
function of HSP90 in yeast.
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Introduction 
The 90-kDa heat shock protein (HSP90)1 has been demonstrated to be an 
important molecule, chaperoning a variety of cellular proteins, such as steroid receptors 
(1-3), protein kinases involved in signal transduction (4-6), and even retrovirus reverse 
transcriptase (7) and endothelial nitric oxide synthase (8, and see reviews 9, 10).  
HSP90 occupies a central part of the chaperone network, the “foldsome,” and functions 
in cooperation with other chaperones and co-chaperones, such as immunophilins, 
CDC37/p50, HSP70, p23, Hip, Hop/p60 and PA28 (11-13 and see reviews 9, 10).  This 
assembly process of the HSP90-substrate protein complex requires ATP (14, 15), which 
induces a conformational change in HSP90 (16-18).  Recently, it was demonstrated 
that HSP90 is capable of linking substrates for degradation by the ubiquitin-proteasome 
pathway, by co-operating with the E3 ligase CHIP (19-21).  Thus HSP90 may play a 
central role in deciding the fate of proteins, refolding or degradation. 
HSP90-family proteins are composed of 3 regions at the primary structure level 
(22, 23).  In present study using human HSP90a, we denote the N-terminal region, 
Met1-Arg400, as Region A; the middle region, Glu401-Lys615, as Region B; and the 
C-terminal region, Asp621-Asp732, as Region C (23).  The N-terminal domain 
(residues 9-232) defined as the ATP/geldanamycin-binding region (24, 25), the tertiary 
structure of which has been clarified (24-26), corresponds to the N-terminal half of 
Region A.  Prodromou et al. (25) observed a dimeric crystallographic structure of the 
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N-terminal ATP-binding domain of yeast HSP90.  Subsequently, they showed an 
ATP-dependent dimerization of the N-terminal domain independent of the C-terminal 
dimeric region (27).   
Region B and Region C mediate dimerization of the HSP90-family proteins; 
Region B of one subunit is associated with Region C of another subunit in an 
anti-parallel fashion (22).  Electron microscopy showed that an HSP90 dimer consists 
of 4 linearly-arranged globules (18), and the N- and C-terminal immunogenic sites (23) 
were localized in the terminal and interior globules, respectively (28). 
To accomplish the molecular function of HSP90, each region may have 
additional roles that should be unveiled.  For instance, although the ATP binding site 
has been localized toward the amino terminus of HSP90, ATP binding as well as 
elevated temperature bring about a profound conformational change that is not restricted 
to the ATP-binding domain (16-18).  When the concentration of HSP90 was lower than 
1 mM, both of ATP binding and elevated temperature induced an equivalent 
conformational change, converting HSP90 from a linear dimer into an O-ring-shaped 
structure (18).  On the other hand, when the concentration of HSP90 was sufficiently 
high, HSP90 self-oligomerized instead of formed O-ring-shaped molecules, probably 
through essentially identical interactions (29).  Alteration of the regional interaction 
may be closely related to these conformational changes.  In this connection, we 
recently proposed that the liberation of the N-terminal client-binding region from the 
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middle suppressor region is the mechanism underlying the temperature-dependent 
activation of HtpG, an E. coli homologue of mammalian HSP90 (30). 
Our previous study on limited proteolysis of human HSP90a strongly 
suggested the existence of sub-regional structures within the respective 3 regions (23).  
Further structural and functional analyses on potential sub-structures presented 
difficulty because of limited information on regional functions in those days.  We 
recently reported the regional structures and their interactions of HtpG (28).  As a 
result, several characteristics of HtpG and HSP90 regions emerged, which provided us 
the probes for investigation of the sub-regional structures of HSP90. 
In the present study, we investigated potential sub-regional structures in the 3 
regions of HSP90 responsible for the regional interactions and further investigated the 
role of the regional interactions of HSP90 in vivo by using budding yeast, 
Saccharomyces cerevisiae.  We demonstrate that the intra-molecular interaction 




Materials - Expression vector pQE9 and plasmid pREP4 were purchased from Qiagen 
Inc. (Chatsworth, CA, U.S.A.); and low-molecular-weight and peptide markers, from 
Amersham Pharmacia Biotech (Uppsala, Sweden).  Restriction enzymes and 
DNA-modifying enzymes were from Nippon Gene (Tokyo, Japan).  Talon metal 
affinity resin was obtained from Clontech Laboratories Inc. (Palo Alto, CA, U.S.A.).  
Trypsin (5,200 USP units/mg protein), chymotrypsin (11000 AcTyrOEt hydrolyzing 
units/mg protein) and Na-acetyl-L-tosyl-L-phenylalanine chloromethyl ketone were 
purchased from Sigma (St. Louis, MO, U.S.A.).  Yeast protein extraction reagent 
Y-PER was from Pierce (Rockford, IL, U.S.A.).  Bacterial strain BTH101 (F-, cya-99, 
araD139, galE15, galK16, rpsL1(Strr), hsdR2, mcrA1, mcrB1) and plasmids pKT25kan 
and pUT18Camp were generously provided by Drs. D. Ladant (Pasteur Institute, Paris, 
France) and L. Selig (Hybrigenics, S. A., Paris, France).  All other reagents were of 
analytical grade. 
 
Construction of bacterial expression vectors - The DNAs encoding the full-length form 
of human HSP90a (31) and E. coli HtpG (32) were generously provided by Drs. K. 
Yokoyama (Riken Life Science Center, Tsukuba, Japan) and E. A. Craig (University of 
Wisconsin Medical School, Madison, WI, U.S.A.), respectively.  Construction of the 
plasmids carrying the full-length form of HSP90a and HtpG tagged with a histidine 
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hexamer, designated pH6HSP90a and pH6HtpG, respectively, and their regions (A or 
BC) were described previously (28, 33).  Y1090 [pREP4] was transformed with the 
plasmids and selected on Luria broth agar plates containing 50 mg/ml of ampicillin and 
25 mg/ml of kanamycin.   
 
Expression and purification of recombinant proteins - H6HSP90a, H6HtpG and their 
truncated forms were expressed and purified by use of Talon affinity resin according to 
the manufacturer’s protocol, except that 10 mM imidazole was added in the 
lysis/washing buffer.  Bound proteins were eluted with 0.1 M imidazole (pH 8.0) 
containing 10% (v/v) glycerol.   
 
Substitution of conserved amino acids in Region B – Three amino acids within Region 
B were substituted with Ala in human HSP90a, E. coli HtpG and yeast HSC82 by 
site-directed mutagenesis in combination with the DpnI-degradation elimination of 
template DNA.   The mutations were confirmed by DNA sequencing.  Leu477, 
Glu517 and Leu592 of human HSP90a (34) are equivalent to the respective Leu416, 
Glu456 and Leu532 in E. coli HtpG (34) and to Leu453, Glu493 and Leu567 in yeast 
HSC82 (35).  Throughout the present study, we use the amino acid numbers of human 
HSP90a to refer to these 3 amino acids for simplicity. 
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Bacterial 2-hybrid system – Minimal regions responsible for the interaction between 
Region A and Region B were determined by the bacterial 2-hybrid system according the 
method of Karimova et al.  (36).  The DNA fragments encoding Region A of HSP90a 
and its truncated forms amplified by PCR were inserted into pKT25kan, designated 
pKT25-HSP90aA (1-400), pKT25-HSP90a222-400 and so on (see Fig.  3a).  The 
DNA fragments carrying Region B of HSP90a and its truncated regions were amplified 
by PCR and inserted into pUT18Camp, designated pUT18C-HSP90aB (401-618), 
pUT18C-HSP90a401-600 and so on (see Fig. 3b).  The complex formation between 
co-expressed recombinant proteins was quantified by b-galactosidase activity as 
described previously (36).  Values were reported as means of 3 or 4 samples and 
expressed as percents of that activity in the bacteria co-expressing non-truncated Region 
A and Region B (100%). 
 
Yeast expression system – Temperature sensitivity of yeast cells expressing mutated 
forms of yeast HSC82 was examined as described previously (37).  5CG2HIS 
(MATaura3-52 lys2-801amber ade2-101ochre triple- ⊿ 63 his3- ⊿ 200 leu2- ⊿ 1 
hsc82::HIS3 hsp82::GAL1-HSP82::LEU2) is a strain whose endogenous HSC82 gene 
was disrupted and HSP82 gene was controlled with a GAL1 promoter (37).  The strain 
forms colonies on SGal plates by the expression of HSP82, but not on SD plates.  A 
DNA fragment encoding the full-length form of yeast HSC82 cut out with SfcI and 
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blunt-ended was inserted into a blunt-ended BamHI site of the GPD promoter of a 
multicopy plasmid, pYO326GPD (38), designated pYO326GPD-HSC82.  The colony 
formation was examined on SD plates at 25 or 37oC for 3 days and 14oC for 2 weeks 
following the introduction of pYO326GPD-HSC82.  Transformants grew on both SD 
and SGal plates at 14-37oC. 
 
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and protein 
sequencing - Electrophoresis was performed at a polyacrylamide concentration of 
12.5% in the presence of 0.1% SDS.  In cases (Figs. 1 and 2) where fine separation of 
proteins smaller than 20 kDa was required, the Tris-Tricine system at a polyacrylamide 
concentration of 10% was employed (39).  Separated proteins were stained with 
Coomassie Brilliant Blue.  Low-molecular-weight and peptide markers were used as 
references.  For determination of the N-terminal sequences of proteolytic fragments, 
separated proteins in a polyacrylamide gel were electro-transferred to a polyvinylidene 
difluoride membrane (Bio-Rad).  After having been stained with Coomassie Brilliant 
Blue, the excised bands were directly subjected to sequencing with a model 477A 
protein sequencer (PE Biosystems). 
 
Immunoblotting analysis – Yeast cells (pYO326GPD-HSC82 and 
pYO326GPD-HSC82-L477A/E517A) cultured in SD medium overnight at 30oC were 
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diluted to 0.15 in absorbance at 600 nm in 50 ml of the same medium and then further 
cultured at 30 or 37oC for 6h.  The cells were lyses with Y-Per at 2.5 ml/g cell 
precipitate.  SDS-PAGE and immunoblotting were performed thereafter as described 
previously (23).  An anti-HSP90 monoclonal antibody, K41220 (10 mg/ml), was used 
as the first antibody.  K41220 binds to human HSP90a and HSP90b with equal 
efficiency (23).  It recognizes one of the most immunogenic region of human HSP90a, 
N291KTKPIWTRNPDDI304, (34) of which 2 amino acids (underlined) are replaced in 
human HSP90b (N283KTKPLWTRNPSDI296) (40) and yeast HSC82  
(N267KTKPLWTRNPSDI280) (35) as described previously (23).  Alkaline 
phosphatase-conjugated goat anti-mouse IgG was used as the second antibody at a 
1:2500 dilution.  Kaleodoscope prestained standard (Bio-Rad) was used as molecular 
markers. 
 
Polyacrylamide gel electrophoresis under nondenaturing conditions – In order to 
estimate molecular configurations, recombinant proteins and their mixtures were 
subjected to PAGE on a 7.5% polyacrylamide gel under nondenaturing conditions (41).  
We found that elution buffers, i.e. 0.1 M imidazole (pH 8) containing 10% (v/v) 
glycerol for H6HtpG, did not interfere with the interaction between recombinant proteins.  
Accordingly, purified proteins were used without any further treatment in this study.  
Electrophoresis was performed at room temperature unless otherwise described.  
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Separated proteins were stained with Coomassie Brilliant Blue.  Ovalbumin (45 kDa), 
bovine serum albumin (66 kDa as monomer, 132 kDa as dimer and 198 kDa as trimer) 
and catalase (240 kDa) were used as references. 
 
Protein concentration - Protein concentrations were determined by the bicinchoninic 
acid method (Pierce, Rockford, IL, U.S.A.).  
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Figs. 1 and 2 
 
RESULTS 
Limited proteolysis of Region A - We first performed limited proteolytic analysis of 
HSP90a.  To make the interpretation simple, we here used the regions of HSP90a 
instead of the full-length form.  Limited proteolysis of Region A with trypsin produced 
a limited number of proteolytic fragments (Fig. 1a). At the lowest trypsin concentration, 
the 52-kDa Region A was split into 15- and 40-kDa fragments (lanes 2-4).  At 
moderate and higher trypsin concentrations, the respective 30- (lanes 4-7) and 10-kDa 
(lanes 6-8) fragments appeared.  The 40- and 10-kDa fragments had an N-terminus 
identical to that of the intact form.  The 15-kDa fragment had 2 adjacent N-termini 
starting at Glu282 and Tyr284 (Table I).  The 30- and 40-kDa fragments were also 
produced by limited proteolysis of the full-length HSP90a (23), which implies that the 
proteolytic pattern is identical between the full-length form and Region A.  
Interestingly, the 40-kDa fragment was still blotted by an anti-HSP90 monoclonal 
antibody K41102, which recognizes residues 247-257, but the 30-kDa fragment was not 
blotted by it (23).  Therefore, the 40- and 15-kDa fragments seemed to consist of 
amino acids 1-281/283 and 282/284-400, respectively; and the 30-kDa fragment was 
derived from the 40-kDa species by deletion of the highly charged region 
(Glu223-Lys283), as schematically illustrated in Fig. 1b. 
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An identical technique was applied to Region A (Met1-Arg336) of E. coli HtpG. A 
major tryptic site (Arg236-Asn237) and chymotryptic site (Trp234-Thr235) were 
identified (data not shown and see Fig. 7a). 
 
Tables I and II 
 
Limited proteolysis of Region B – Next we performed limited proteolysis on Region B.  
Unfortunately, Region B of HSP90a was not quantitatively recovered from the bacterial 
expression system employed, presumably because the recombinant protein was unstable.  
Hence, we expressed Glu401-Asp732, which consisted of Region B and Region C 
(designated as Regions BC).  The 42-kDa Regions BC was split into several fragments 
including 14- and 27-kDa fragments at low trypsin levels (Fig. 2a).  At moderate 
trypsin concentrations, 6.5-, 20- and 24-kDa fragments appeared.  At higher 
concentrations, 8- and 19-kDa fragments accumulated.  Among them, the 14-kDa 
fragment was the most resistant to a wide range of trypsin concentrations (lanes 2-6).   
N-terminal sequencing revealed that the 14-kDa fragment started at Asp621 (Table 
II), implying that the fragment corresponded to Region C, as expected.   The 
N-terminal sequence of the 27-kDa fragment was identical to that of the original 
fragment, indicating that the 27-kDa entity represented Region B.  The N-termini of 
the 24-, 20- and 19-kDa fragments were Asn415, Leu447 and Leu459, respectively.  
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Thus, the 27-kDa Region B was successively degraded at the N-terminal side into 24-, 
20- and 19-kDa fragments.  In addition to the N-terminal truncation, an 8-kDa 
fragment was obtained by cleavage at the C-terminal side of 27-kDa Region B.  Taken 
together, the 42-kDa Regions BC was initially split into the 27-kDa Region B and the 
14-kDa Region C, and the former was further processed into the smaller fragments at 
cleavages of Lys414-Asn415, Lys446-Leu447, Lys458-Leu459 or Lys546-Glu547 (Fig. 
2b).  It should be noted that a 22-kDa fragment carrying the N-terminal two-thirds of 
Region B was observed on limited proteolysis of the full-length form (23) but that such 




Minimal regions sufficient for the interaction between Region A and Region B - 
Next we determined the minimal regions required for the interaction between Region A 
and Regions B by using a bacterial 2-hybrid system.  As shown in Fig. 3a, an 
interaction between Region A and Region B was ascertained.  This interaction reflects 
the intra-molecular interaction of an intact molecule, as reported recently (28).   
HSP90a222-400 and HSP90a289-400, i.e. truncations from N-terminus to Phe221 and 
to Glu288, respectively, still possessed considerable binding activities.  A further 
deletion up to Gly310 resulted in a loss of the binding.  In contrast, even the smallest 
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deletion (28 residues) from the C-terminus of Region A caused complete loss of the 
activity.  Thus, the minimal region of Region A required for the binding to Regions BC 
was defined as residues 289-400. 
We then defined the minimal region of Region B for binding to Region A (Fig. 
3b).  When the C-terminus of Region B was serially deleted, residues 401-546 retained 
complete binding to Region A, but residues 401-541, i.e. an additional 5-amino acid 
deletion, resulted in complete loss.  It should be emphasized that one of the tryptic 
cleavage sites in Region B was Lys546-Glu547 (Table II).   To the contrary, even a 
20-amino acid deletion of the N-terminus resulted in complete loss.   Thus, residues 
401-546 are the minimum requirement for the binding to Region A.   From these 2 
experiments, we conclude that residues 289-400 of Region A are associated with 




Table III and Fig. 4 
 
Effect of substitution of conserved amino acids in Region B - The Region A-Region 
B interaction is maintained in both E. coli HtpG and human HSP90a and Region B of 
one species can be replaced by that of the other species in vitro (30).  Thus amino acids 
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within Region B conserved among the HSP90-family members should be important for 
the interaction.  Within Region B of human HSP90a (34), HSP90b (40), human 
TRAP1 (mitochondrial form) (42), human GRP94/gp96 (endoplasmic reticulum form) 
(43), E. coli HtpG (32) and yeast HSC82 (35) and HSP82 (44), there are 28 identical 
amino acids, of which 25 and 3 residues are distributed in the sequence of residues 
401-546 and 547-615, respectively.  So we expressed Regions BC with amino acid 
substitutions and tested their bindings to Region A: two of them (Leu477 and Glu517) 
were arbitrary chosen from the N-terminal sub-site, and one (Leu592) from the 
C-terminal one. 
The 2-hybrid system revealed that the amino acid substitution in Region B of 
human HSP90a (Leu477 or Glu517 to Ala) caused this region to lose its ability to bind 
Region A, whereas the substitution at position 592 from Leu to Ala still allowed 29% of 
the binding (Table III).   Thus, consistent with the results on the truncated forms of 
Region B (Fig. 3b), the conserved amino acids, Leu477 and Glu517, located in the 
N-terminal sub-site (residues 401-546) of the region were essential for the binding to 
Region A; whereas Leu592, located in the C-terminal sub-site (residues 547-615), was 
not crucial.  We also performed the experiment in the hybrid combination of these 
mutated HSP90aBC and HtpGA, substituting HSP90aA, and obtained an identical 
binding profile (Table III).  
Although the 2-hybrid analysis provided convincing results on positive data, 
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there might be several interpretations on negative ones.  For instance, steric hindrance 
caused by the fusion with a protein encoded by a vector might prevent the interaction of 
a protein of interest.  Therefore, we further examined the effect of the mutations on the 
regional interaction by use of purified regions in vitro.  Because the regions of human 
HSP90a readily self-oligomerize even under non-stress conditions (30), we here 
expressed the regions of HtpG as substitutions that carried mutations at equivalent 
positions.  Purified preparations of Region B (H6HtpGB) of HtpG and its mutated 
forms as well as those of Region A (H6HtpGA) migrated as a single band on SDS-PAGE 
(Fig. 4a) and on PAGE under nondenaturing conditions (Fig. 4b, lanes 1-7).  The upper 
shift of H6HtpGB-E517A might have been caused by the reduction in the acidity (Fig. 
4b, lane 4).  A retarded band appeared after mixing of H6HtpGA and H6HtpGBC (lane 
8).  After mixing of H6HtpGBC-L477A or H6HtpGBC-E517A with H6HtpGA, 
retarded bands (lanes 9 and 10) still appeared and were indistinguishable from the 
H6HtpGA-intact H6HtpGBC complex (lane 8).  Then, we expressed H6HtpGBC with 
double mutations, i.e. H6HtpGBC-L477A/E517A.  Retardation was scarcely detected, 
and most of the recombinant proteins migrated to the unaltered positions (lane 11).  
This phenomenon was specific for H6HtpGBC-L477A/E517A, because double 
mutations of alternate pairs still possessed considerable binding abilities (lanes 12 and 
13). 
  We recently reported the temperature-dependent dissociation of the interaction 
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between Region A and Region B of HtpG, which appears to be closely related to the 
function of the molecular chaperone (30).  Accordingly, we further examined the effect 
of temperatures on the interaction between H6HtpGA and mutated H6HtpGBC.  
Essentially all H6HtpGBC associated with H6HtpGA at 4-37oC (Fig. 4c, lane 4, arrows).  
In contrast, the complex formation between H6HtpGA and H6HtpGBC-L477A/E517A 
was drastically reduced at all temperatures tested (lane 5, arrows).  Nevertheless, it 
should be noted that some extents of the complex formation were consistently observed 
at 4 and 20oC.  The complex was still observed at 30oC, but was scarcely present at 
37oC.  Thus, we conclude that a single substitution at either Leu477 or Glu517 to Ala 
was not sufficient for the complete disruption of the intra-molecular interaction when 
the 2 regions were feasibly accessible but that the simultaneous replacement of the 2 
amino acids could completely abrogate the interaction in particular at 37oC. 
  In order to investigate the conformational changes of H6HtpGBC induced by the 
amino acid substitutions, H6HtpGBC and its mutated forms were subjected to limited 
proteolysis to trypsin and papain.  Figure 4d demonstrated that 
H6HtpGBC-L477A/E517A was highly sensitive to trypsin.  Moderate susceptivity was       
observed on H6HtpGBC-E517A.  H6HtpGBC-L477A as well as an intact form was 
resistant to trypsin under the conditions employed.  Papain treatment revealed the same 
order of sensitivity (data not shown).  Thus, the double-amino acid substitutions 
seemed to significantly affect the tertiary structure of Regions BC.  In the final part of 
 20 
our study, we investigated whether these mutations would affect the in vivo function of 




Region A-Region B interaction is important in vivo - Yeast 5CG2HIS strain, which 
expressed yeast HSP82 under the control of galactose-regulated promoter, formed 
colonies at 14-37oC on galactose-, but not on glucose-containing plates (37).  After the 
introduction of pYO326GPD-HSC82, which resulted in constitutively expressed intact 
HSC82, the yeast strain formed colonies at 25-37oC on glucose plates, on which 
expression of HSP82 was repressed.  Yeast strains that expressed HSC82 with a single 
amino acid substitution, L477A or E517A, or with a double mutation, L477A/L592A or 
E517/L592, also formed colonies at both temperatures on glucose plates (Fig. 5a and b).  
In contrast, the strain that carried HSC82 with L477A/E517A double mutations grew at 
25oC (Fig. 5a) and 30oC (data not shown) but not at 37oC on glucose plates (Fig. 5b).  
Therefore, mutated HSC82 that was deficient in the Region A-Region B interaction 
brought the yeast cell to high-temperature sensitive, suggesting that the interaction 
between Region A-Region B is essential in vivo. 
  Immunoblotting analysis of yeast HSC82 was performed with an anti-HSP90 
monoclonal antibody K41220.  After cultivation either at 30 or 37oC for 6h, an 82-kDa 
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band was found in all cases (Fig. 6b), i.e., yeast cells expressing intact HSC82 or 
HSC82-L477A/E517A at both temperatures.  The intensity was more predominant at 
37oC, presumably simply reflecting elevated metabolism at higher temperatures.  
Therefore, the selective proteolytic break down of HSC82-L477A/E517A protein was 
unlikely to explain the growth inhibition of the yeast cells, but a functional defect 
should occur.   
Taken together, the defect in the interaction between Region A and Region B  
H6HtpGBC-L477A/E517A especially at lower temperatures (Fig. 4c) indicate the 
molecular basis that produced the high temperature-sensitive mutant of the yeast.  
Yeast strains that carried any mutated HSC82 were not cold (14oC) sensitive and had no 
dominant negative effect (data not shown). 
 
DISCUSSION 
In the present study, we performed analytically limited proteolysis of Region A and 
Regions BC of HSP90a using bacterially-expressed protein fragments, to predict the 
sub-region structures of these regions.   To apply this technique, one should carefully 
consider whether their proteolytic profile might be altered from that of the full-length 
form.   The tryptic pattern of Region A appeared to be identical to that of the 
full-length form; i.e. the major 40- and 30-kDa fragments shown in Fig. 1a were also 
observed in our previous analysis using the full-length HSP90a (23).   
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On the other hand, the tryptic pattern of Region B seemed to be slightly different 
between the region fragment and the full-length form.  That is, the 27-kDa Region B 
produced from the full-length form was further processed to a 22-kDa species by a 
cleavage at the C-terminal side (23), but this entity was not formed on proteolysis of the 
region because of preferential N-terminal break down (Table II).  The present study on 
Regions BC demonstrated that the Lys546-Glu547 bond corresponded to this site 
producing the 22-kDa species (Table II).  Therefore, the limited proteolytic analyses 
using recombinant fragments reproduced, even if but partially, the cleavage profile of 
the full-length form, which made it possible for us to predict the sub-region boundaries. 
One might raise a possibility that the proteolysis occurred in exposed surface loops 
within a domain.  If such fragments were formed, they would possess sticky 
hydrophobic patches, which would allow interaction with various fragments.  However, 
as exemplified in Table II, the tryptic cleavage at Lys546-Glu547 in Regions BC, and  
as shown in Fig. 3b, the C-terminal deletion of 5 amino acids from residues 401-546 to 
401-541 of Region B caused a complete loss of the binding to Region A.  A similar 
phenomenon was observed on tryptic cleavage sites (Lys281-Glu282 and 
Lys283-Tyr284 ) of Region A (Table I) and the region (residues 289-400) responsible 
for the binding to Region B  and (Fig. 3a).  These findings strongly suggested the 
accordance of the structural and functional units on HSP90a.  Moreover, it should be 
noted the primary tryptic site within Region A was not located within the highly charged 
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region (residues 223-283), but was the edge of it.   
Region A of HSP90a was divided into two fragments, 40 and 15 kDa.  
Notably, cleavage sites of Region A of HSP90a and HtpG were located at close 
positions (Fig. 7a).  From both of those structural and functional analyses, Region A of 
HSP90a should be divided into 2 sub-regions, i.e. residues 1-283 and 284-400.  The 
former comprises the ATP-binding domain (residues 9-222) and highly charged region 
(residues 223-283) (Fig. 7c).  In view of its high charge density and immunogenic 
properties (23), the highly charged region may be exposed to the outer surface of the 
molecule.  This region appears to be dispensable for viability and signal transduction 
in yeast (45), but might have a role in modulating the function of the ATP-binding site 
(46). 
The common cleavage site (Lys546-Glu547) in both the full-length form and 
Regions BC may be located at the boundary between functional entities.  In fact, this is 
likely because residues 401-546 were sufficient for binding to Region A, but a further 5 
amino acid deletion resulted in null binding (Fig. 3b).  Moreover, our previous studies 
demonstrated that the C-terminal portion of the region was sufficient for binding to 
Region C; that Val542-Tyr627 was associated with Region C after chymotryptic 
proteolysis (22) and that the C-terminal one-third of HtpG (Gln481-Lys552), equivalent 
to residues Val542-Ala618 of HSP90a was capable of binding to Region C (28).  
Therefore, it is reasonable to conclude that the C-terminal portion of Region B interacts 
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with Region C.  In Region B of HtpG, trypsin attacked a site almost identical to that of 
chymotrypsin, and the 2 sites are relatively close to the tryptic site of HSP90a (Fig. 7b 
and ref. 22).  Therefore, Region B can be divided into two sub-regions: sub-region BI 
(residues 401-546) specific for binding to Region A and sub-region BII (residues 
547-615) for interaction with Region C.  
We recently proposed that liberation of Region A from Region B is important 
for the chaperone activity of HSP90 (30).  So as to verify our hypothesis, we 
substituted amino acids of sub-regions BI and BII conserved among HSP90-family 
members.  As a result, the double mutant (L477A/E517A) within the sub-region BI, 
whose product did not associate with Region A, was unable to support the growth of 
HSP82-depleted yeast cell at 37oC.  Importantly, the yeast cell could grow at 14-30oC, 
but not at 30oC, which faithfully reflected the temperature dependence of the complex 




Fine resolution of the region- and sub-region structures of HSP90 and their 
roles, as presented in Fig. 7c, has provided the molecular basis for systematic analyses 
of amino acids screened by mutational studies.  The present study on 
temperature-sensitive yeast strain that carries HSC82-L477A/E517A is the first example 
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of such analyses.  Although the previous studies (37, 47, 48) reported the mutations of 
HSP90 that caused yeast cells to be high-temperature sensitive, the underlying 
mechanism remains unknown.  In contrast, the mechanism on the temperature 
sensitivity on double mutations of yeast HSC82 reported in this study seems to be 
readily attributed to the defect in the intra-molecular interaction between sub-regions 
AII and BI (Fig. 4c).  Moreover, it is reasonable to assume that potential client proteins 
are increased at elevated temperatures, which may additionally contribute to the growth 
defect of the yeast at higher temperatures.  In this respect, it is interesting to investigate 
whether or not the 4 and 3 point mutations (asterisks in Fig. 7c) occurring in 
sub-regions AII and BI, respectively, reported in previous studies (37, 47, 48) actually 
cause the functional defect through the disruption of the regional interaction of HSP90. 
In conclusion, the present study describes for the first time the mechanism on 
the high-temperature sensitive mutation in vivo, in coupled with the in vitro functional 
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1The following abbreviations are used: HSP90, the 90-kDa heat shock protein; HSP90a 
and HSP90b, the a and b isoforms of HSP90, respectively; HSP82 and HSC82, heat 
shock protein 90 and heat shock cognate protein 90, respectively, of the budding yeast, 
Saccharomyces cerevisiae; HtpG, an E. coli homologue of mammalian HSP90; 
GRP94/gp96, the 94-kDa glucose-regulated protein (endoplasmic form of HSP90); 
TRAP1, mitochondrial form of HSP90; GST, glutathione S-transferase; PAGE, 







Fig. 1. Limited proteolysis of Region A – (a) Histidine-tagged Region A of HSP90a 
(HSP90aA, 50 mg/25 ml) was incubated for 6 h at 30oC without (lane 1) or with 0.001, 
0.003, 0.01, 0.03, 0.1, 0.3 and 1 mg (lanes 2-8) of trypsin that had been treated with 
Na-acetyl-L-tosyl-L-phenylalanine chloromethyl ketone.  Then, aliquots (5 mg) were 
subjected to SDS-PAGE using the Tris-Tricine system.  Apparent molecular masses of 
major fragments are indicated on the left.  M, low-molecular-weight and peptide 
markers.  The remainders of the digests were separated as above, and then the 
separated fragments were subjected to N-terminal sequencing.  (b) Tryptic peptides are 
aligned according to their N-terminal sequences and apparent molecular masses.  
Hatched boxes represent an N-terminal histidine tag (M-12-R-G-S-H6-G-S-1) preceding 
the first Met of HSP90a.  N-terminal amino acids of the fragments are shown on the 
boxes. 
 
Fig. 2. Limited proteolysis of Regions BC – (a) Histidine-tagged Regions BC of 
HSP90a (HSP90aBC, 50 mg/25 ml) was incubated for 6 h at 30oC without (lane 1) or 
with 0.002, 0.006, 0.02, 0.06, 0.2, 0.6 and 2 mg (lanes 2-8) of trypsin that had been 
treated with Na-acetyl-L-tosyl-L-phenylalanine chloromethyl ketone.  Thereafter, 
aliquots (5 mg) were subjected to SDS-PAGE using the Tris-Tricine system.  Apparent 
molecular masses of major fragments are indicated on the left.  M, molecular markers.  
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N-terminal sequencing of the fragments were performed as in Fig. 1a. (b) Tryptic 
peptides are aligned according to their N-terminal sequences and apparent molecular 
masses.  Hatched boxes represent an N-terminal histidine tag preceding Glu401.  
N-terminal amino acids of the fragments are shown above the bars. 
 
Fig. 3. Minimal regions essential for the Region A-Region B interaction – (a) Region A 
and its truncated forms expressed in the pKT25kan vector are schematically represented.   
Closed, hatched and dotted boxes, respectively, represent the ATP-binding site (residues 
9-222), highly charged region (residues 223-283) and immunogenic site I (residues 
227-310) (23).  These plasmids were co-expressed with pUT18Camp-HSP90aB.  (b) 
Region B and its truncated forms expressed with pUT18Camp vector are schematically 
represented.  They were co-expressed with pKT25kan-HSP90aA.  The 
b-galactosidase activities of the bacteria co-expressing Region B and Region A (100%) 
or their truncated forms were determined.  Values are represented as per cents + S.D. 
of 3 samples.  Control means a combination with plasmids, pKT25kan and pUT18Camp. 
 
Fig. 4. Polyacrylamide gel electrophoresis of the Region A-Regions BC complex - (a) 
One microgram each of H6HtpGA (lane 1) or H6HtpGBC without (wt, lane 2) or with 
amino acid substitutions (lanes 3-7) as represented above the gel were run on 
SDS-PAGE.  Numbers of substituted amino acids are expressed as those of human 
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HSP90a.  M, low-weight molecular markers.  (b) Recombinant proteins or their 
combined samples (1 mg per protein) as indicated above the gel were run on PAGE 
under nondenaturing conditions.  M, molecular markers.  (c) Recombinant proteins or 
their combined samples (1 mg per protein) were run on PAGE under nondenaturing 
conditions at indicated temperatures.  Electrophoresis was run at a low voltage (50 V) 
for 5-6 h to avoid the temperature increase.  Lane 1, H6HtpGA; lane 2, H6HtpGBC; 
lane 3, H6HtpGBC-L477A/E517A; lane 4, H6HtpGA with H6HtpGBC; and lane 5, 
H6HtpGA with H6HtpGBC L477A/E517A.  M, molecular markers.  (d) H6HtpGBC 
(wt), H6HtpGBC L477A, H6HtpGBC-E517A or H6HtpGBC-L477A/E517A (25 mg/50 
ml) was digested without (lane 1) or with 1 (lane 2) and 3 ng (lane 3) of trypsin at 30oC 
for 6h as described in Fig. 1.  Samples were denatured and an aliquot (4 mg) was run 
on SDS-PAGE.  M, low-molecular weight and peptide markers. 
 
Fig. 5. Effect of amino acid substitutions located in Region B in yeast – Aliquots of 
yeast culture diluted serially one-tenth were spotted on SD plates.  The cells were 
incubated at (a) 25oC or (b) 37oC for 3 days.  wt, wild type of HSC82. 
 
Fig. 6. Immunoblotting analysis of yeast HSC82 – Proteins extracted from yeast cells 
cultured at 30 or 37oC for 6h were run on SDS-PAGE.  (a) Separated proteins and (b) 
yeast HSC82, respectively, were visualized by Coomassie staining and immunoblotting 
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with K41220 as described in Experimental Procedures.  In panel b, marker bands (lane 
M) were visible, because they were pre-stained, not by immunochemical staining. 
 
Fig. 7. Region and sub-region structures of the HSP90-family protein – (a and b) Amino 
acid sequences around major cleavage sites of (a) Region A and (b) Region B are 
compared between human HSP90a and E. coli HtpG.  T and C, respectively, represent 
tryptic and chymotryptic cleavage sites.  Dots and asterisks represent deleted and 
identical amino acids, respectively.  E (20 kDa) represents an endogenous cleavage site 
producing a C-terminal 20-kDa fragment (23).  (c) Three-region (A, B and C) and 
sub-region (I and II) structures of HSP90a and their roles are summarized.  CR, highly 
charged region.  Arrows indicate point mutations, L477A, E517A and L592A, 
introduced in this study.  Mutated amino acids in yeast HSP82 (37, 47, 48) and 
Drosophila HSP83 (49) giving rise to altered phenotypes are mapped (asterisks) on the 
sequence of human HSP90a (34). 
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Table I. N-terminal sequences of tryptic fragments of H6HSP90aA.  Amino acids 
written in small letters are derived from the N-terminal tag peptide.  Arrows indicate 
tryptic cleavage sites. 
                                                              
Fragment Detected amino acids Deduced sequence 
(kDa)                                                         
40  MRGSHHHHHH M-12RGSHHHHHH-3 
 
30a1  RGSHHHHHH  m-12↓r-11gshhhhhh-3 
30b1   RGS   m-12rgshhhhh-4 
 
15a1  YIDQEELNK  K283↓Y284IDQEELNK292 
15b1  EKYIDQEEL    K281↓E282KYIDQEEL290 
 
10  GSHHHHHHGS  r-11↓g-10shhhhhhgs-1 
                                                               
1mixture of two peptides. 
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Table II. N-terminal sequences of tryptic fragments of H6HSP90aBC.  Amino acids 
written in small letters are derived from the N-terminal tag peptide.  Arrows indicate 
tryptic cleavage sites.                                              
Fragment Detected amino acids Deduced sequence  
(kDa)                                                          
27  MRGSHHHHHH m-12rgshhhhhh-3 
 
24  NLVKKXLEL  K414↓N415LVKKCLEL423  
 
21  LGIXEDS  K446↓L447GIHEDS453 
 
19  LSELLRYY  K458↓L459SELLRYY 466 
 
14  DNSTMGYMAA R620↓D621NSTMGYMAA630 
 
 8  EGLELDEDEE  K546↓E547GLELDEDEE556  
 
 6.5a1   MRGSHHHHH  m-12rgshhhhh-4 
 6.5b1  HIYYITGET  K489↓H490IYYITGET498        
1mixture of two peptides.  X, unidentified amino acid. 
 38 
Table III. Effect of point mutations within Region B of HSP90a.  The effect on 
point mutations within Region B of HSP90a was determined in terms of the 
interaction with Region A of HSP90a and HtpG.  The b-galactosidase activities 
to respective intact forms (wt) were set to 100%. 
                                              
pKT25kan- pUT18Camp-  Activity (%)1 
                                              
control control       5.8 + 1.2 
HSP90aA HSP90aBC wt    100.0 + 36.6 
HSP90aA HSP90aBC L477A   6.0 + 1.1 
HSP90aA HSP90aBC E517A   7.7 + 2.6 
HSP90aA HSP90aBC L592A  29.2 + 8.8 
 
control control    15.8 + 1.8 
HtpGA HSP90a wt    100.0 + 27.0 
HtpGA HSP90aBC L477A    17.0 + 2.8 
HtpGA HSP90aBC E517A    13.5 + 2.0 
HtpGA HSP90aBC E517A    45.2 + 24.4 
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Fig. 4 (continued) 
 
1   2  3  4   5       M        1    2   3   4   5       M
4oC                                 20oC　　　　　　　
　　　　　　


















Fig. 4 (continued) 
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Fig. 7 (continued) 
HSP90   530  VQQLKEFEGKTLVSVTK..EGLELPEDEEEKKKQ 561
* ** **   ** *  * **   **
HtpG 468  MNYLTEFDGKPFQSVSKVDESLEKLADEVDESAK 502
HSP90   562  EEKKTKFENLCKIMKDILEKKVEKVVVSNR 601
*  *          *  *   *  *    * 
HtpG    503  EAEKALTPFIDR.VKALLGERVKDVRLTHR 531
T





Fig. 7 (continued) 
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